Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Med Chem ; 150: 920-929, 2018 Apr 25.
Article in English | MEDLINE | ID: mdl-29602038

ABSTRACT

Leishmaniasis is a group of infectious neglected tropical diseases caused by more than 20 pathogenic species of Leishmania sp. Due to the limitations of the current treatments available, chalcone moiety has been drawn with a lot of attention due to the simple chemistry and synthesis, being reported with antileishmanial activity in particular against amastigote form. This review aims to provide an overview towards antileishmanial activity of chalcones derivatives against amastigote form for Leishmania major, L. amazonensis, L. panamensis, L. donovani and L. infantum as well as their structure-activity relationship (SAR), molecular targets and in silico ADMET evaluation. In this way, it is expected that this review may support the research and development of new promising chalcones candidates a leishmanicidal drugs.


Subject(s)
Antiprotozoal Agents/pharmacology , Chalcone/pharmacology , Leishmania/drug effects , Antiprotozoal Agents/chemical synthesis , Antiprotozoal Agents/chemistry , Chalcone/chemical synthesis , Chalcone/chemistry , Dose-Response Relationship, Drug , Drug Design , Humans , Molecular Structure , Parasitic Sensitivity Tests , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...